tradingkey.logo

BRIEF-COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes

ReutersFeb 4, 2025 1:45 PM

-

  • COUR PHARMACEUTICALS SECURES FDA CLEARANCE OF IND APPLICATION FOR CNP-103 IN TYPE 1 DIABETES

Source text: ID:nGNXb1rbjN

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI